Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
29.98B | 32.70B | 28.91B | 32.24B | 35.03B | 28.68B | Gross Profit |
8.23B | 9.69B | 7.96B | 10.29B | 10.25B | 8.41B | EBIT |
3.50B | 4.61B | 3.58B | 5.93B | 5.85B | 4.44B | EBITDA |
7.96B | 8.88B | 6.91B | 9.12B | 9.64B | 6.69B | Net Income Common Stockholders |
3.68B | 4.04B | 3.27B | 4.73B | 5.00B | 3.31B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
12.00B | 13.05B | 7.89B | 8.09B | 9.92B | 7.72B | Total Assets |
57.09B | 59.96B | 54.64B | 52.84B | 49.87B | 45.32B | Total Debt |
4.07B | 3.53B | 4.92B | 3.58B | 2.25B | 3.00B | Net Debt |
-7.93B | -9.52B | -2.97B | -4.51B | -7.67B | -4.52B | Total Liabilities |
12.30B | 13.82B | 11.01B | 11.44B | 10.74B | 10.30B | Stockholders Equity |
44.13B | 45.44B | 42.98B | 40.83B | 38.65B | 34.66B |
Cash Flow | Free Cash Flow | ||||
2.84B | 7.56B | -366.50M | -789.48M | 3.51B | 409.71M | Operating Cash Flow |
2.84B | 8.60B | 4.37B | 4.73B | 5.84B | 4.80B | Investing Cash Flow |
0.00 | -298.37M | -4.13B | -4.85B | -1.04B | -3.98B | Financing Cash Flow |
0.00 | -3.13B | -476.17M | -1.56B | -1.83B | -648.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥55.26B | 13.52 | 3.18% | 6.36% | 17.44% | ||
79 Outperform | ¥59.80B | 7.85 | 2.16% | 5.44% | 8.53% | ||
79 Outperform | ¥54.93B | 5.10 | 4.91% | 4.12% | 192.18% | ||
75 Outperform | ¥54.70B | 11.60 | 10.09% | 2.75% | 17.34% | 44.04% | |
71 Outperform | ¥43.40B | 8.33 | 5.63% | 3.16% | ― | ||
66 Neutral | ¥60.06B | 9.65 | 4.60% | 3.21% | -1.94% | ||
51 Neutral | $2.03B | -1.27 | -21.09% | 3.98% | 2.91% | -30.50% |
Osaka Organic Chemical Industry Ltd. has signed a basic agreement with Shin-Nakamura Chemical Co., Ltd. to establish a joint venture in the United States. This move aligns with their medium-term management plan, Progress & Development 2030, aiming to enhance the sales of specialty acrylic acid esters in the U.S. market. The joint venture is expected to have a negligible impact on the company’s financial results for the fiscal year ending November 30, 2025.
Osaka Organic Chemical Industry Ltd. reported a significant financial performance for the first quarter of the fiscal year ending November 30, 2025, with net sales increasing by 20.5% year-on-year to 8,516 million yen. The company’s operating profit also saw a notable rise of 135.2% year-on-year, attributed to increased sales and reduced depreciation, despite uncertainties in the economic outlook due to external factors.
Osaka Organic Chemical Industry Ltd. reported significant growth in its financial results for the three months ending February 28, 2025, with net sales increasing by 20.5% year-on-year. The company also saw substantial increases in operating profit and ordinary profit, indicating strong operational performance. Despite a decrease in comprehensive income, the company’s capital adequacy ratio improved, reflecting a stable financial position. The inclusion of a new subsidiary in Korea suggests an expansion strategy that could enhance its market presence in Asia.